Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fragmin Extension for Diabetic Foot Ulcers
NCT00765063Phase 3Completed
- Sponsor
- Pfizer
- Start
- Oct 2008
- Primary completion
- Oct 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 14
01
Overview
A Phase 3 trial of dalteparin in diabetic foot ulcer (DFU), sponsored by Pfizer. Started Oct 2008; status: completed.
02
Drugs
dalteparin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00765063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00765063.